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1. Introduction 
The study of drug addiction integrates a broad range of research fields including social 
sciences, psychology, psychiatry, behavioural neurosciences, pharmacology or genetics, 
each of which being represented in the different chapters of this book. Preclinical studies 
involving behaving animals have been pivotal for our increasing insights into the 
psychobiological substrates of addiction and so for about 100 years. Even today, our 
understanding and knowledge of addiction increase in parallel with the refinement of 
animal models of this pathology. 
1.1 Necessity for animal models in drug addiction research 
Whilst animal models can never reproduce the complex social and often personal reasons 
why people abuse drugs they nevertheless provide a rigorous means to precisely control 
environmental context, drug exposure as well as assessing behavioural and cognitive 
performance prior to drug administration. They also allow neural manipulations (e.g., using 
selective ligands) and so establish the causal influences of putative neural loci and, in turn, 
the cellular and molecular substrates, of drug addiction. Thus, to date, animal models 
provide a valuable means to investigate the different stages of the drug addiction cycle 
including especially the initiation of drug taking, the maintenance phase, which is often 
accompanied by binges and escalation of drug intake, and finally the switch to compulsive 
drug intake defined operationally by an increased motivation to take the drug, an inability 
to inhibit drug seeking and continued dug use despite negative or adverse consequences. 
1.2 Definition and validity criteria of animal models 
1.2.1 Definition of an animal model 
An animal model is a preparation in one organism that allows for the study of one or several 
aspects of a human condition. Thus a model of drug addiction must provide insights into 
the neurobiological, psychological or etiological mechanisms of the pathology in humans, at 
least mimicking some aspects of the pathology. 
Two strategies are generally used when designing animal models of drug addiction. Firstly, 
the model can address a specific symptom, a neurobiological or psychological feature or  
a behavioural / neurobiological construct associated with the pathology (figure 1).  
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Fig. 1. Animal models of drug addiction in reference to the DSM IV diagnostic criteria for 
drug addiction (adapted from the DSM-IV [97])) 
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These models have been widely developed the last 40 years and have provided substantial 
informations about the molecular targets of addictive drugs as well as the neurobiological 
and psychological adaptations resulting from either acute or chronic drug exposure. Indeed, 
models that focus on defined features of drug addiction provide a powerful heuristic 
framework for determining the brain mechanisms underlying the pathology. However, they 
rarely address other clinical dimensions of the disorder such as behavioural predictive 
factors or interactions between different symptoms of the pathology. Thus, the second type 
of models are those that try to incorporate several symptoms of the pathology in humans, 
thereby providing powerful tools for longitudinal studies or even testing pharmacological 
treatments, but are somewhat limited in the identification of underlying mechanisms. 
Indeed, the behavioural complexity of these models makes it difficult to implement causal 
investigative studies where the end-point is well defined. We discuss the general utility and 
application of both modelling approaches as complementary tools to investigate the 
neurobiological and psychological mechanisms of drug addiction and its vulnerability. 
1.2.2 Validity criteria of animal models 
The validation of animal models of addiction is based upon the same principles that have 
been established for models in general, namely fulfilling standard criteria amongst which 
reliability and predictive validity are the most important [1]. However, there are other 
criteria that have been used widely in validating animal models of drug addiction, including 
face validity and construct validity [1]. Briefly, reliability refers to the consistency and 
stability with which the independent and the dependent variables are measured. Thus a 
reliable model of drug addiction must allow for a precise and reproducible manipulation of 
the independent variable and an objective and reproducible measure of the dependent 
variable in standard conditions. A further key criterion for the validation of an animal 
model is its predictive validity. A valid animal model should predict either the therapeutical 
potential of a compound in humans (pharmacological isomorphism) or a variable that may 
influence both the dependent variable of the model and the process under investigation in 
humans. 
Face validity refers to the similarities between the dependent variable of the model, i.e., 
behaviour in the case of drug addiction, and the human condition, i.e. the symptoms of the 
pathology. Thus face validity may be important in designing the model but is unlikely an 
objective criterion to actually assess its validity. Indeed, it is very difficult, if not impossible, 
to provide an objective criterion to evaluate the similarities between the behavioural output 
of a rat preparation and drug addiction in humans when the behavioural repertoire of the 
two species is so different. 
Construct validity has been increasingly considered in animal models of drug addiction. It 
refers to the ability of a model to take into account psychological or neurobiological 
constructs that characterise the specific pathological processes in humans. Thus, incentive 
sensitisation, habit formation or top-down prefrontal executive control failure are examples 
of constructs which have been investigated in animal models. 
2. Reinforcing effects of drugs of abuse, abuse liability  
As previously mentioned all addictive substances show reinforcing properties in animals. 
Indeed, the abuse liability of a substance is often measured by its ability to support self-
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administration and a conditioned place preference [2]. In this section are reviewed the 
experimental designs that have been developed to investigate the reinforcing properties of 
addictive drugs. These procedures, combined with molecular biology and pharmacology, 
have been crucial in the identification and functional characterisation of the molecular 
targets of addictive drugs. 
The seminal discovery by Olds and Milner of intra-cranial self-stimulation (ICSS) in 1954 
marked a major turning point for research on the neural mechanisms of addiction [3]. The 
discovery that dopaminergic projections from the ventral tegmental area (VTA) to limbic 
cortico-striatal structures (nucleus accumbens, Acb), olfactory tubercle, amygdala, 
orbitofrontal cortex (OFC), medial prefrontal cortex (mPFC) were effective substrates for 
ICSS sparked considerable interest in the brain dopamine systems as neural substrates for 
the rewarding properties of both natural [food] and drug reinforcers. A few years later 
Weeks developed an operant procedure to deliver intravenous morphine infusions to 
relatively unrestrained rats [4], a method still widely used in many pre-clinical research 
laboratories today. That research continued on the opioid drugs morphine and heroin for 
some considerable time thereafter was no surprise given the strong emphasis at that time in 
the DSM-III on the symptomatology of opioid dependence and withdrawal [5]. 
Since then it has been established that addictive substances exert powerful effects on 
primary and secondary (i.e. conditioned) reinforcement mechanisms. As instrumental 
reinforcers they strongly encourage behaviours that lead to the availability of a drug, a 
process subserved by stimulus-response associative mechanisms (instrumental 
conditioning). Abused drugs also facilitate Pavlovian conditioning whereby previously 
neutral stimuli in the environment become conditioned to the drug, and can predict it, or 
even act as conditioned reinforcers. 
In operational terms, a reinforcer is a stimulus that increases the probability of a response 
consequent upon its presentation. Thus, all addictive drugs are reinforcers since they are 
self-administered by animals and humans and support conditioned place preference (a form 
of contextual Pavlovian conditioning). Pavlovian conditioned stimuli can act as conditioned 
reinforcers when presented contingently. Then they can have powerful motivational effects 
and support long sequences of instrumental drug-seeking behaviour by bridging delays to 
future drug reinforcement [6-8]. 
2.1 Conditioned place preference 
Conditioned place preference (CPP), has been used extensively to probe the psychological 
[9] and neurobiological [10-11] mechanisms underlying the rewarding properties of 
addictive drugs [10;12], as well as negative emotional states associated with drug 
withdrawal [13-15]. Indeed, through Pavlovian conditioning, the negative affective state 
caused by drug withdrawal can induce a reliable conditioned place aversion [13-15]. 
The first study based on the modern paradigm of CPP was reported by Rossi and Reid in 
1976 [16] although earlier demonstration of preference for a drug paired environment was 
published as early as the 1940’s [10]. In this procedure two different unconditioned stimuli 
(US) are paired with two distinct environments. These contextual cues differ in their spatial 
configuration, colour, flooring, and sometimes even olfactory cues. Briefly, the CPP 
procedure involves injecting animals with either the drug in question or a control solution, 
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each being administered in a different environment often over successive days. The 
conditioning phase may combine several pairings, ideally according to a Latin square and 
unbiased design such that every pairing does not predict subsequent pairings, and that any 
spontaneous bias or preference for a compartment is initially controlled for. CPP is then 
tested during a drug-free choice phase where subjects are given access to both 
compartments. Preference for the drug-paired environment is indicative of the rewarding 
properties of the drug. CPP can be established not only for addictive drugs but also for 
natural rewards such as food, water, sexual partner and novelty [10]. Based on a plethora of 
studies, it is widely accepted that increased dopamine transmission is necessary for the 
establishment of CPP [17]. Although some authors suggest that CPP is a model of drug 
seeking behaviour [or drug craving], being essentially dependent upon Pavlovian 
associations, CPP alone cannot account for the instrumental nature of drug seeking and 
drug taking behaviour, which is perhaps better modelled by drug self-administration 
procedures. 
2.2 Drug self-administration models 
Drug self-administration procedures lie at the core of the most sophisticated preclinical 
models of drug addiction that have been developed over the last twenty years, ranging from 
relapse to drug taking [18-20], to loss of control over intake [21-22], compulsive drug taking 
[23-25] and addiction-like behaviour [8;26-28]. 
Addictive drugs act as reinforcers, in that they increase the probability of a behavioural 
response that leads to their presentation, through instrumental conditioning. Thus, animals 
can readily detect the contingency between an instrumental response and the delivery of a 
particular drug (e.g., an intravenous infusion of heroin, cocaine, nicotine or THC, or a small 
volume of alcohol in a magazine) and respond in an instrumental manner to obtain such 
drugs. The acquisition of drug self-administration is a behavioural marker of its reinforcing 
properties and abuse liability [2]. Indeed, apart from LSD, all drugs abused by human are 
self-administered by animals. 
Drugs of abuse can be self-administered by a variety of routes across preclinical models, 
including intramuscular, intranasal, oral, and intravenous [29]. 
Drug self-administration was initially developed in non human primates, however since the 
pioneering work of Weeks (1962), rats have extensively been used to investigate the 
psychological, neural and cellular mechanisms underlying drug self-administration. 
Self-administration procedures can be arranged according to different schedules of 
reinforcement [29]. In fixed ratio schedules, the drug is delivered after the completion of a 
fixed number of responses by the animal, thereby providing a direct relationship between 
the actual response and drug delivery. By contrast, in fixed interval schedules, the animal is 
trained to seek the drug for prolonged periods of time. 
Different schedules allow for the investigation of different processes of drug taking or drug 
seeking behaviour which are beyond the scope of this chapter. However, insightful 
descriptions of, and discussions about, these schedules can be found in [6;29-32]. 
The acquisition of drug self-administration is widely considered to depend on the functional 
integrity of the olfactory tubercle and the shell of the nucleus accumbens (AcbS) [7]. An 
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important role for mesolimbic dopamine in this process was inferred by findings in freely 
moving rats that dopamine concentration is greatly increased in the striatum, and especially 
the Acb, following the self-administration of drugs commonly abused by humans [33]. This 
important study supported the influential hypothesis at that time that addictive drugs exert 
their primary reinforcing effects and addictive properties through activation of the 
mesolimbic dopamine system [34-37]. Although it is now clear that increased dopamine 
release in the Acb does not provide a sufficient account for the addictive properties of drugs 
such as cocaine, alcohol and heroin, dopamine still remains one of the most important 
neurotransmitters in the aetiology and pathophysiology of drug addiction, a role 
underscored by its proposed involvement in salience detection and learning [7;38-52]. 
In its classic form, the drug self-administration paradigm has provided valuable insights 
into the brain substrates mediating drug taking behaviour, which differ somewhat 
according to the particular drug under investigation [53-56]. Addictive drugs not only 
influence the function of the mesolimbic dopamine system [33] they also trigger a variety of 
between-systems anatomical [57-62] and functional neuroadaptations [63-66] as well as 
changes in gene transcription and function in a number of brain systems including the 
hypothalamus [67], the VTA [68], the amygdala [69-74], Acb [75-79], dorsal striatum [80], 
orbital [81-82] and prefrontal cortices [83-85], with important effects on stress responsivity 
[86-88] and epigenetic processes in the limbic system [77;89-92]. 
However, even though these data have increased our knowledge about the neurobiological 
substrates of the reinforcing effects of addictive drugs and the neurobiological adaptations 
to drug self-administration, they provide only limited insights into the neurobiology of drug 
addiction. As very well brought to remembrance by Serge Ahmed [93], intravenous 
(intrajugular) self-administration of saline had been demonstrated in water-deprived 
monkeys [94] a year before the pioneer morphine self-administration work in rats of Weeks 
(1962), thereby demonstrating that drug self-administration is a measure of instrumental 
conditioning, but not really a model of drug addiction. 
Thus, when one considers working on drug addiction one has to keep in mind that studying 
drug taking behaviour is not a way of studying drug addiction. This was already stated long 
ago by Wise and Bozart [95] and quoted by Robinson & Berridge [96]: “To assert that all 
addictive drugs are reinforcers is to do little more than redefine the phenomenon of 
addiction.”…”To identify a drug as reinforcing goes no further than to identify the drug as 
addicting“; indeed, there is an obvious gulf between taking a drug on a social basis, as most 
of us often do, at least when one considers a glass of wine, and compulsively taking drugs. 
Nevertheless, even after the publication of the DSM-IV in 1994 [97] and the new diagnostic 
criteria for compulsive drug use that now form the hallmark of the clinical features of drug 
addiction many, if not all, of the early animal models focused on the “rewarding“ properties 
of addictive drugs and their acute and chronic neurobiological effects. 
Thus, during the last ten years pre-clinical research in drug addiction has attempted to 
better integrate one or more clinical features of the pathology according to the DSM-IV 
diagnostic criteria. New phenotypes have been identified based on craving or either 
reinstatement [20;98-99] or relapse to drug seeking [100], a loss of control over drug taking 
[21-22], habitual / compulsive cocaine seeking and taking [6;23-25;101] and inter-individual 
vulnerability to addiction-like behaviour [8;26-28]. 
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3. Monodimensional animal models of addiction 
3.1 Craving and relapse 
Drug addicts show a high propensity to relapse, even after protracted abstinence [102]. This 
hallmark feature of addiction can be modelled in animals using two main procedures: 
extinction-reinstatement, initially developed by Stewart and colleagues [18-19] and 
abstinence-relapse [103]. Reinstatement of responding for drug can be induced by stress, 
low doses of the drug itself and by the presentation of drug-associated cues [20;104-112]. In 
the extinction-reinstatement procedure [18-19], animals experience a series of extinction 
sessions following a short period of drug self-administration, leading to a progressive 
decline in responding. Following extinction, responding for drug is reinstated by a stressful 
stimulus, a priming injection of drug, a presentation of a conditioned stimulus (CS) or by 
placing the animal in a drug-associated environment. 
Reinstatement of drug seeking depends upon a broad neurobiological network which 
subsets are recruited based on the nature of the trigger of reinstatement, be it stress, the 
drug or drug associated cues and context [105]. Overall, reinstatement to drug seeking 
depends upon the extended amygdala, prefrontal cortex and dopaminergic neurons 
[105;113-114]. A large impetus has recently been put on the prominent role of glutamate 
homeostasis in reinstatement to drug seeking, especially focusing on prefrontal – accumbens 
pathways [111;115-116]. 
Interestingly, it has been shown that levels of reinstatement induced by contingent 
presentations of drug-associated cues increase with prolonged time of withdrawal. This 
observation suggests that drug craving increases with withdrawal duration [117-118], an 
adaptation that was specifically related to increase dopamine transporter (DAT) and N-
Methyl-D-Aspartate receptor 1 (NMDA R1) protein levels in respectively the prefrontal 
cortex and the mesolimbic system [118]. However, incubation process has also been 
reported for food and fear, thereby suggesting that it is a common neurobehavioural 
adaptation to cessation of stimulation, whatever the nature of the unconditioned stimulus, 
rather than a specific neurobiological substrate of drug addiction. 
In the abstinence-relapse procedure [103], animals are given a forced abstinence period after 
a brief period of drug self-administration. They are then maintained in their home cage until 
they are exposed again to the self-administration chamber where they are tested under 
extinction. 
Whereas the reinstatement procedure clearly involves the Acb and both its dopaminergic 
and glutamatergic inputs, relapse to drug seeking depends upon the dorsolateral striatum 
[100;103]. Thereby, this neurobiological dissociation suggests that parallel, not necessarily 
mutually exclusive, neurobiological systems are involved in relapse to drug seeking. 
However, their respective contribution to the human craving and relapse situation remains 
unclear, especially the one of reinstatement since the situation in which human addicts go 
through extinction before responding to drug-associated stimuli or stress is very unfrequent. 
3.2 Escalation of drug taking 
The first well-established animal model of loss of control over drug intake, namely 
escalation of drug self-administration, is based on the fourth diagnostic criterion of drug 
addiction and was developed by Serge Ahmed and George Koob in 1998 for cocaine [21] 
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and 2000 for heroin [22]. Short access (“ShA“) to addictive drugs generally results in stable 
levels of self-administration such that plasma drug levels are controlled within an optimal 
level of reinforcement [119]. As mentioned previously, this pattern of self-administration 
does not account for the clinical features of drug addiction in humans. Ahmed and Koob 
thus gave extended access to cocaine to a group of animals (“LgA“, or long access) following 
a period of moderate exposure (ShA, fixed ratio 1, one hour a day). A second group of rats 
received short access to cocaine throughout the experiment. 
Introduction of the long access was immediately associated with higher drug intake, as 
compared to ShA rats. In other words, the LgA rats escalated their rate of cocaine self-
administration compared with ShA rats, which maintained a constant level of cocaine intake. 
LgA rats also exhibited higher rates of cocaine self-administration during the first hour of each 
session. Escalation of cocaine intake has been associated with an upward shift in the 
intracranial self-administration threshold (ICSS), indicative of reward dysfunction [21] that has 
been postulated by the hedonic allostasis theory [2;86-88]. However, escalation of cocaine self-
administration is not associated with psychomotor sensitisation but, instead, with a 
sensitization of the incentive motivational properties of cocaine [120], thereby suggesting a 
dissociation between loss of control over drug intake and behavioural sensitisation. 
Escalation of drug intake has also been associated with higher resistance to shock-induced 
suppression of drug self-administration and conditioned suppression [24;121], and therefore 
might contribute to the instantiation of addiction. 
However, all rats subjected to extended access to heroin do not necessarily escalate their 
intake [122]. Thus, when the upper and lower quartile of a population of Lister-Hooded rats 
are selected on the basis of the escalation slope (a direct measure of the magnitude of 
escalation of drug intake over time), marked differences can be observed [122]. Whereas low 
escalation (LE) rats show a marked increase in their intake when extended access is 
introduced and then reach a plateau in their daily drug intake, high escalation (HE) rats 
tend to show a slower adaptation to extended access, in that they do not increase their 
intake as quickly as LE rats, but progressively lose control over heroin self-administration 
(figure 2). This first formal description of inter-individual differences in the propensity to 
escalate heroin intake lead to the investigation of the behavioural markers of loss of control 
over heroin and cocaine intake (see “Vulnerabilities to drug addiction” section). This 
observation may resonate well with the demonstration that escalation of drug intake does 
not necessarily render rats insensitive to alternative reinforcers, i.e., despite escalation of 
cocaine self-administration rats have been reported to prefer a saccharine solution when 
given the choice between this reinforcer and the drug [123]. This suggests that schedule-
induced escalation of drug intake, when considered without the individual dimension, does 
capture one criterion of drug addiction, namely, drug is used in larger amounts, but not 
necessarily extends to other criteria. However, inter-individual differences can also be 
observed in the resistance to alternative reinforcers after extended access to cocaine [93]. 
3.3 Animal models of drug seeking: The distinction between drug seeking and drug 
taking behaviour: Second-order and two-link heterogeneous chained schedules of 
reinforcement 
Drug addiction does not involve only taking drugs, drug addicts spend most of their time 
foraging for the drug. It is therefore vital to dissociate drug taking from drug seeking. In 
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trying to separate drug seeking from drug taking, schedules of reinforcement must be 
implemented in which operant responding for the drug during the drug seeking phase is 
not affected by the drug itself, i.e., so that drug seeking behaviour can be measured without 
interference by stimulant or sedative actions of the self-administered drug. 
 
Fig. 2. Inter-individual propensity to lose control over heroin intake, after (122) 
Marked inter-individual differences were revealed when the upper (high-escalation rats, HE, n=5) and 
lower quartile (low-escalation rats, LE, n=5) of a population of lister hooded rats were selected based on 
the slope of drug intake over all 18 days of the LgA phase [group: F1,8 = 59.44, P < 0.001]. Thus, HE and 
LE rats displayed a different profile both in terms of heroin intake (A) and escalation ratio (B) [group x 
session interaction: F22,176 = 8.26, P < 0.001 and F16,128 = 10.20, P < 0.001, respectively]. Post-hoc analysis 
confirmed that HE rats displayed a daily increase in both intake and escalation ratio from the 4th and 
6th day of extended access, respectively (vs. LgA d1, all Ps < 0.05), whereas LE rats showed no 
escalation at all.  
Two-link heterogeneous chained schedules of reinforcement aim to dissociate spatially, 
temporally, and instrumentally drug seeking from drug taking behaviour. Second-order 
schedules of reinforcement allow the investigation of cue-controlled drug seeking over 
prolonged periods of time. 
3.3.1 Two-link heterogeneous chain schedules of reinforcement 
In this procedure completion of the first link of the chain, designated as the seeking link, 
results in access to the second link, or taking link, which permits, once performed, the delivery 
of the reinforcer. Acquisition of the chain schedule is achieved through successive steps of 
increasing complexity which start with introduction of the taking lever. A lever press is then 
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reinforced under a fixed ratio (FR) 1 schedule so that each lever press produces drug 
reinforcement accompanied by the withdrawal of the taking lever. After several sessions of 
stable responding, the seeking lever is introduced while the taking lever is retracted. The first 
press on the seeking lever initiates a random interval (RI) schedule with the first seeking lever 
press occurring after the RI has elapsed terminating the first link of the chain; this results in 
retraction of the seeking lever and insertion of the taking lever to initiate the second link. One 
press on the taking lever results in the presentation of the reinforcer followed by a time-out 
period. Thereafter, the seeking lever is reinserted to start the next cycle of the schedule. The 
effects of experimental manipulation can thus be assessed through measures of seeking 
responding (latency, number or response rate) as well as taking responding (latency). The 
interest in dissociating seeking and taking behaviour is obvious when considering that the two 
instrumental components are influenced by dissociable processes since they are differentially 
sensitive to devaluation, incentive learning or Pavlovian manipulations [124]. In addition, 
cocaine seeking performance is monotonically related to the dose of drug with a relatively 
long time out [125]. Whereas early cocaine seeking performance is profoundly affected by 
extinction of the taking link [126-127] but not by inactivation of the dorsolateral striatum [127], 
after extended training it becomes automatic, i.e., insensitive to extinction of the taking lever 
and sensitive to inactivation of the dorsolateral striatum [127], thereby suggesting a shift in 
both the psychological and neurobiological mechanisms governing drug seeking when it 
becomes well established [128]. 
3.3.2 Second-order schedule of cocaine reinforcement 
In the street, drug seeking behaviour is stimulus-bond in that drug addicts forage for their 
drug under the control of stimuli in the environment, acting as conditioned reinforcers, that 
support long sequences of behaviour in the absence of the outcome. More formally, 
conditioned reinforcers are stimuli that have themselves acquired rewarding properties after 
repeated associations with unconditioned rewards. Conditioned reinforcers bridge delays 
between seeking and obtaining the drug. Psychostimulants, opiates, speedball, cannabis, or 
nicotine-associated CSs act as powerful conditioned reinforcers since they greatly enhance 
drug seeking behaviour when presented contingently, but not non-contingently, upon 
instrumental responding during, usually, interval schedules of reinforcement [6;30;32;129-
130]. Conditioned reinforcers can also support the acquisition of a new instrumental 
response [131-132]. Such properties are clearly demonstrated in procedures where animals 
work to obtain presentation of a conditioned stimulus, often in the absence of the 
unconditioned reward. 
In second-order schedules of reinforcement, the CS is presented response-contingently 
usually under a fixed ratio schedule, during an overall fixed interval or fixed ratio schedule 
for the primary reinforcer, and markedly enhances and maintains responding for long 
periods of time (figure 3). Thus, under a second-order schedule of reinforcement, a strong 
contingency exists between the instrumental response and the presentation of the CS (under 
a fixed ratio) as well as the relatively weaker contingency that is arranged between 
instrumental performance and the outcome (the drug) that is reinforced only after 
completion of the first ratio after each interval has elapsed. Such schedules therefore 
facilitate the development of stimulus-response (S-R) control over instrumental responding. 
In addition, it has been shown that omission of CS presentation in second-order schedules of 
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reinforcement disrupts cocaine seeking more than food seeking behaviour [130], suggesting 
that prolonged psychostimulant seeking is particularly dependent upon conditioned 
reinforcement. 
Thus, instrumental responding during the first interval of a second-order schedule of 
reinforcement shows face and construct validity with regards to the behavioural features of 
drug seeking in humans: stimulus-bound, somewhat dissociated from the unconditioned 
effects of the drug and long lasting. 
 
Fig. 3. Acquisition of cocaine seeking under a second-order schedule of reinforcement. 
Instrumental performance of a population of 24 Lister Hooded rats during the first interval of a FI15 
and FI15(FR10:S) schedule of reinforcement (see text for explanation). Once animals have acquired self-
administration under continuous reinforcement, the reinforcement schedule is switched to fixed 
intervals, with daily increments: FI1 min, FI2 min, FI4 min, FI8 min, FI10 min, and FI15 min. After 3 
days of training under the FI15 schedule (left part of the figure), contingent presentations of the CS are 
introduced under a FR10 schedule such that rats are now trained under a FI15(FR10:S) second-order 
schedule of reinforcement. This acquisition procedure provides a direct measure of the potentiation of 
responding during interval schedules by the contingent presentation of the CS since they are introduced 
only once responding under fixed interval has stabilized. Thus, although the average response rate is 50 
during the first interval of a FI15 schedule, it reaches 90-100 when the CS is contingently presented 
(Belin-Rauscent & Belin, unpublished). 
Second-order schedules of cocaine and heroin self-administration were initially developed 
by Goldberg and colleagues in non human primates to assess the influence of environmental 
stimuli upon drug self-administration [30;129-130]. Everitt and colleagues have also 
established second-order schedules of drug reinforcement in rats [133]. In the study by 
Arroyo and colleagues (1998), rats were initially required to learn cocaine to self-administer 
under continuous reinforcement, i.e., FR1. After stabilisation of responding, (5 to 7 daily 2 
hours sessions), a second-order schedule with fixed ratio components of the type FRx(Fry:S) 
was introduced, with initial values of x and y set to 1, so that each active lever press resulted 
in the presentation of the CS and and the delivery of 0.25 mg of cocaine. Then x and y values 
were progressively increased with increments in response requirements starting with x i.e., 
FR5(FR1:S) and FR10(FR1:S), then y, i.e., FR10(FR2:S), FR10(FR4:S), FR10(FR7:S) and 
FR10(FR10:S). After stabilisation of responding under this FR10(FR10:S) schedule of 
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reinforcement which therefore requires 100 active lever presses and 10 one second 
presentations of the CS to obtain a cocaine infusion, a final fixed interval schedule 
FI15(FR10:S) was introduced such that a cocaine infusion was delivered only following the 
tenth active lever press that occurred when the 15 min interval had elapsed. Finally rats 
were allowed to perform cocaine seeking behaviour under this schedule for ten days. This 
acquisition procedure produces robust and stable CS-dependent rates of responding [133] 
and has been used extensively to probe the neural mechanisms involved in the acquisition, 
and the performance of, cue-controlled cocaine-seeking [101;134-135]. 
It is also possible to decrease the acquisition period to 11 days [101;136] (figure 3). In this 
case the training phase consists of three days of FR1 training, 2 hour daily sessions, 30 
infusions (0.25 mg cocaine / infusion) followed by the introduction of interval schedules, 
with daily increments: FI1 min, FI2 min, FI4 min, FI 8 min, FI10 min, FI15 min. After three 
days of training under the FI15 schedule, contingent presentations of the CS are introduced 
under a FR10 schedule such that rats are now trained under a FI15(FR10:S) second-order 
schedule of reinforcement. This acquisition procedure provides a direct measure of the 
potentiation of responding during interval schedules by the contingent presentation of the 
CS since they are introduced only once responding under fixed interval has stabilised. 
Thus, although the average response rate is 50-70 during the first interval of a FI15 schedule, 
it reaches 100-150 when the CS is contingently presented (figure 3), as described in several 
studies from Everitt’s laboratory [101;137-138]. Indeed, short and long-term training under 
second-order schedules of reinforcement for cocaine have been very useful for investigating 
the neural mechanisms involved in the transition from newly acquired to well established or 
habitual cue-controlled cocaine seeking. Thus, acquisition of cue-controlled cocaine seeking 
depends upon the core of the Acb (AcbC) and its functional relationships with the 
basolateral amygdala [139] as well as dopamine transmission into the posterior dorsolateral 
striatum [137]. However, when it is well established, or habitual, cue-controlled cocaine 
seeking rather depends upon dopamine transmission into the dorsolateral striatum and its 
functional relationship with the AcbC, as demonstrated by functional disconnections 
between these two structures [101]. 
A dorsomedial to dorsolateral striatal shift in the control over drug seeking has recently 
been demonstrated to occur in alcohol self-administration after eight weeks of training 
[140a] and cocaine seeking after two weeks of training under an FI15(FR10:S) schedule of 
reinfocement [140b], a stage at which alcohol seeking was shown to be impervious to 
devaluation, i.e., was habitual. Thus addiction to both stimulants and alcohol may be 
dependent upon a shift from goal-directedness to habits that parallels, at the neural systems 
level, a progressive recruitment of the dorsolateral striatum. These data obtained in 
preclinical models resonate well with the recent demonstration of dorsal striatum 
implication cue-induced in alcohol [141] or cocaine [142] craving in humans. 
3.4 Animal models of compulsive drug seeking and drug taking 
As emphasised previously, addicted individuals not only consume large amounts of drugs 
but are also unable to repress their drug use regardless its consequences. Thus addiction 
shares common features with other compulsive disorders which are characterised as the 
uncontrollable and irresistible urge to performance an act, often to relieve anxiety or stress, 
but regardless of the rationality of the motivation. 
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The compulsive aspect of drug use in addicted subjects is even more obvious when 
similarities between addiction and obsessive compulsive disorder (OCD) are considered. 
Indeed, compulsive behaviour in the 4th version of the DSM [97] as a criterion for OCD is 
defined by the repetitive behaviours or mental acts that the person feels driven to perform 
in response to an obsession, or according to rules that must be applied rigidly aiming at 
preventing or reducing distress or some dreaded event or situation; but are either not 
connected to the issue or are excessive. Similarities between addiction and OCD have led, 
based on a modified version of the Yale–Brown Obsessive Compulsive Scale (Y-BOCS-hd) 
[143-144], to the development of the Obsessive Compulsive Drinking Scale (OCDS), a self-
rated questionnaire which is able accurately to discriminate between alcoholic out-patients 
and social drinkers with high sensitivity and specificity [145], suggesting that obsessionality 
and compulsivity are key features of the heavily addicted individual [145]. 
Clinical data on abstinence from cocaine use suggest that the negative consequences directly 
related to use are a major reason for cessation [146]. Indeed, drug use is a high risk 
behaviour as it often compromised health, work and social relationships [147-148]. 
Preclinical models of drug addiction might therefore attempt to resemble in several respects 
the human conditions of compulsivity and fulfil some important features of the pathology in 
order to meet the necessary requirements of construct, face and predictive validity essential 
for the clinical application of data obtained from animal studies [1]. Of course, in animals it 
is extremely difficult to exactly reproduce compulsive drug seeking and taking as seen in 
human drug addicts because of obvious limitations including the absence of direct personal 
costs such as family or society problems associated with drug abuse, or limited alternative 
reinforcement choices. 
However, despite such limitations, compulsivity in preclinical models of drug addiction 
should and must be defined as an inability to cease drug seeking and taking under 
conditions in which the drug is constantly available but its obtainment is associated with 
adverse consequences. 
In recent years, progress has been made in an attempt to mimic human conditions of 
compulsive drug use. 
3.4.1 Maintained drug use despite adverse consequences 
1. Resistance to devaluation / adulteration 
In addition to their reinforcing properties, most addictive drugs have toxic effects, which 
after repeated use can lead to severe health complications. Such aversive properties would 
normally progressively devalue any reinforcer, and facilitate the engagement of the subject 
in alternative responses, incompatible with the pursuit of the initial reinforcer. However, 
despite often acknowledging the deleterious outcome of drug use, addicts rarely achieve 
spontaneous voluntary abstinence, and when they manage to do so, often relapse to 
compulsive drug use. 
Similarly, rats differentially respond to devaluation of drugs of abuse and natural 
reinforcers. Performance for food is markedly affected by pairing its ingestion with illness 
produced by injection of lithium chloride. In contrast, devaluation of orally administered 
alcohol and cocaine does not greatly decrease drug seeking performance [140;149-150]. 
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Similarly, extended access to free choice between drug solutions and water interrupted by 
periods of withdrawal in rats results in high levels of drug intake even when solutions are 
adulterated with bitter tasting quinine, evidencing the compulsive pattern of alcohol 
drinking after protracted exposure to the drug [151-153]. 
2. Conditioned suppression 
Until drug users explicitly experience the aversive consequences of drug use, drug taking is 
mainly moderated through warnings rather than actual punishment. Once experienced, 
aversive stimuli temporally distant from drug intake can appear, thereby rendering aversive 
contingencies less distinguishable. Moreover, the aversive consequences of drug use are 
counter-conditioned by previously extended drug presentation, which has been described as 
retarding the development of the conditioned emotional response [154]. All these processes 
may facilitate the attribution of aversive consequences to irrelevant stimuli. Adding a 
stimulus previously associated with an aversive outcome to the training context should 
normally reduce the frequency of a conditioned response. Indeed, although the aversive 
stimuli are not directly associated with drug use itself, a conditioned suppressor may be 
viewed as ‘devaluing’ the drug reinforcer since subjects would be required to respond for 
the drug in a state of conditioned fear [121]. 
However, Vanderschuren and Everitt (2004) found that the presentation of a Pavlovian 
conditioned fear stimulus after an extended self-administration training history failed to 
suppress cocaine self–administration, whereas after a brief cocaine taking history it did. 
These data support the view that while instrumental behaviour directed at obtaining drugs 
is initially a flexible, goal-directed form of behaviour, following prolonged drug exposure, 
drug seeking becomes insensitive to signals of punishment, thereby indicating its 
compulsive nature. However, it remains unclear whether in the multi-operant environment 
that drug addicts are normally exposed to, presentation of aversive conditioned stimuli may 
favour avoidance rather than abstinence. 
4. Punishment 
Aversive stimuli might eventually be perceived as directly associated with drug use. 
Punishment has often been debated as a treatment procedure, both in terms of its ethical 
acceptability and its efficacy. Nevertheless, it remains an undoubtedly important component 
of the every day life of drug addicts. 
In animals, even though differing in many procedural parameters such as the locus or 
intensity of punishment, foot shock-induced punishment has been used in several recent 
models of compulsive drug seeking and drug taking behaviour. Thus we will focus here on 
this punisher, although foot shock-induced suppression may not easily be generalised to the 
human condition. 
In most of the studies on drug taking despite adverse consequences, mild foot shocks, set at 
a constant intensity, are applied contingently upon a response reinforced by a constant dose 
of drug. In this case resistance to punishment is assessed through the persistence of the 
instrumental response despite contingent delivery of the punisher. Alternatively, the degree 
of response suppression is both dependent upon the magnitude of the reinforcer, the 
intensity of the punishment event, the schedule of their respective presentation and the 
delay between the instrumental responses and their consequences [155]. 
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Consequently, Cooper et al. [156] increased daily by 0.04 mA the intensity of a shock that 
was initially set to 0.25 mA until rats stopped responding (lever pressing) during the 30 min 
daily sessions for three consecutive days. Whereas such a procedure has the advantage of 
assigning for each rat the final shock intensity that led to self-imposed abstinence, it 
constrains the opportunity for repeated testing when required. 
The punishment contingency has been used at different loci of the instrumental drug taking 
action. Thus taking [157] or seeking behaviour [24] have been specifically punished. Since 
preparatory and consummatory responses have been shown to be under the influence of 
dissociable processes [158], it is conceivable they are differentially sensitive to punishment. 
In order to assess the sensitivity of seeking and taking responses to punishment Pelloux et 
al. used punishment in the seeking taking task that spatially and temporally dissociates the 
“preparatory” and “consummatory” behaviours [125]. Pelloux et al. conducted a study 
where either 50% of the seeking sequences where associated with the delivery of a shock 
instead of the activation of the taking lever or 50% of the instrumental responses on the 
taking lever were punished. With this probabilistic schedule of punishment both types of 
punishment induced a progressive suppression in performance but punishment of the 
taking response resulted in less suppression than punishment of the seeking response. 
Finally, the efficacy of the punishment of drug seeking or taking seems to greatly depend on 
drug history. After short exposure to amphetamine or an opiate (remifentanil) punishment 
produces robust suppression of self-administration that resumed for the opiate in all 
subjects approximately 5 days after punishment was discontinued [159]. However, the 
punishment effect obtained for amphetamine lasted much longer [157]. After extended 
access to cocaine, punishment produced suppression of a seeking response except in a 
subgroup of animals (about 25%). Thus, compulsive drug seeking appears, as in humans, 
only after extended exposure to the drug in a small proportion of subjects conferring on 
these models good predictive validity. 
5. Multidimensional animal model of drug addiction: addiction-like behaviour 
As previously presented, there are two main strategies when developing preclinical models 
of drug addiction. The first category refers to models developed to understand the 
psychobiological, neurological, cellular and molecular processes involved in a particular 
aspect of the pathology. Therefore, these models specifically address one aspect of the 
pathology, whether a diagnostic criterion, such as escalation of intake, resistance to 
punishment, high motivation for the drug, habitual instrumental performance, vulnerability 
to relapse, or impaired cognitive flexibility. They may also be relevant to influential theories 
such as behavioural sensitisation [44;96;160-161] and hedonic allostasis [2;86-88]. Such 
models generally assume that drug exposure triggers rather similar behavioural, neural or 
molecular effects in all the subjects tested. 
However, these models cannot address other crucial aspects of drug addiction, such as inter-
individual differences in the vulnerability to develop the pathology and their behavioural 
and biological correlates. They also fail to capture the multi-symptomatic nature of drug 
addiction. Thus, the second category of animal models of drug addiction takes into accounts 
both inter-individual differences and the complementary strategy of meeting diagnostic 
criteria of the pathology in humans according to the DSM-IV. Thus, to be diagnosed as 
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‘addicted’ an individual must fulfil three out of seven diagnostic criteria of drug addiction 
over the last 12 months. This approach forms the basis of a new pre-clinical animal model 
based on vulnerability to addiction-like behaviour in the rat [26]. 
In this model, three diagnostic criteria, namely [i] an inability to refrain from drug seeking, 
[ii] high motivation for the drug, and [iii] maintained drug use despite negative 
consequences, have been operationalised by, respectively, [i] drug seeking during periods 
when the drug is not available and signalled as so, [ii] break points during progressive ratio 
schedules of reinforcement, and [iii] persistence of self-administration despite punishment 
by contingent electric foot-shocks. 
When the population is large enough, as it has been the case in several of our studies [26;28], 
a systematic analysis of the distributions of each of the three addiction-like behaviours 
revealed that the distribution of the motivation for the drug and the persistence of drug 
seeking (n=40) were best fitted by a log-normal regression (Khi² and K-S: p>0.05, R2 = 0.96 
and 0.99, respectively) (figure 4, left and middle panel). In contrast the distribution of 
resistance to punishment was bimodal, composed of a first log-normal distribution (n=27 or 
67.5% of the total population, K-S: d = 0.22451, p>0.1), and a second normal sub-distribution 
(n=13 or 32.5% of the total population, K-S: d = 0.15604 p>0.1) (figure 4, right panel) which 
general regression fit can be described as a 3 order polynomial equation y=3.24x3 + 37.33x2 
+130.86x +146.67 [28]. 
 
Fig. 4. Distribution of each of the addiction-like criteria, after (28) 
The distribution of motivation for the drug and persistence of drug seeking (left and middle panel, 
respectively) (n=40) were best fitted by a log-normal regression (Khi2 and K-S: P>0.05). In contrast the 
distribution of resistance to punishment was bimodal, composed of a first log-normal distribution (n=27 
or 67.5% of the total population, K-S: d=0.22451, p> 0.1) , and a second normal sub-distribution (n=13 or 
32.5% of the total population, K-S: d=0.15604, p>0.1) (right panel) which general regression fit can be 
described as a 3 order polynomial equation: y=3.24x3+37.33x2+130.86x+146.67 
The bimodal nature of the distribution of resistance to punishment we demonstrated in this 
study is in agreement with the observation of Pelloux et al. [24]. Bimodal distributions are 
very common in life science literature, especially during speciation process [162] whereby 
one whole population is somehow giving birth to two independent populations [163]. Rare 
in behavioural neuroscience, bimodal distributions have however been observed for drug-
induced behaviours [164], suggesting that the neurobiological substrates of behavioural 
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inter-individual differences need in some cases to be challenged in order to reveal bimodal 
distribution. Our results suggest that a specific subpopulation in the rat has diverged so that 
it has become specifically more vulnerable to maintain drug use despite averse 
consequences, as measured as resistance to punishment, when chronically exposed to the 
drug. This hypothesis, although speculative, when transferred to the human situation may 
actually resonate well with the Nesse and Berridge’s suggestion that the vulnerability to 
drug addiction is a matter of evolution [165]. 
In practical terms, this bimodal distribution is particularly handy because it provides us 
with an objective criterion to determine a threshold in the population in order to carry out a 
dichotomous, categorial, strategy to identify animals that show addiction-like behaviour, 
i.e., 30-40% highest part of the population, depending on the study. Thus, for each of these 
three addiction-like criteria animals are ranked according to their score. If a rat’s score is 
included in the 30-40% highest percentile of the distribution, this rat is considered positive 
for that addiction-like criterion and is given an arbitrary criterion score of 1. Then the 
arbitrary criteria scores for each of the three addiction-like criteria are added, and 
consequently four distinct groups are identified according to the number of positive scores: 
0 criteria, 1 criterion, 2 criteria and 3 criteria rats (figure 5). 
 
Fig. 5. Selection strategy of rats addicted (3crit rats) and rats resistant (0crit rats) to cocaine 
Data analysed from (11). For each of these three addiction-like criteria animals are ranked according to 
their score. If a rat’s score is included in the 30-40% highest percentile of the distribution, this rat is 
considered positive for that addiction-like criterion and is given an arbitrary criterion score of 1. Then 
the arbitrary criteria scores for each of the three addiction-like criteria are added, and consequently four 
distinct groups are identified according to the number of positive scores: 0 criteria, 1 criterion, 2 criteria 
and 3 criteria rats 
Behaviourally, the categorial selection is associated with a criteria-dependent magnitude in 
each of the addiction-like criteria (figure 6). Our model is based on the comparison of three 
criteria (3crit) and 0 criteria (0crit) rats. 3crit rats show high scores for each of the three 
addiction-like criteria and are therefore considered “addicted“, whereas 0crit rats are 
considered resistant to addiction. 3crit rats represent approximately 20% of the population 
exposed to cocaine, an incidence observed in several independent studies with Lister-
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Hooded or Sprague-Dawley rats as well as either nose-poke or lever press as instrumental 
response [26;28;101;166], that is remarkably similar to that reported in humans [167]. 
 
Fig. 6. Behavioural characterisation of addiction-like behaviour in the rat 
A dichotomous approach to the diagnosis of addiction-like behaviour can be implemented in preclinical 
models of addiction on the understanding that some, but not all, animals chronically exposed to drug 
self-administration eventually develop one or more behavioural features resembling a clinical criterion 
for drug addiction as defined in the DSM-IV (see table 13.1). Thus we have operationally defined three 
addiction-like criteria, namely, (i) an inability to refrain from drug seeking (A), (ii) maintained drug use 
despite aversive consequences (B) and (iii) increased motivation to take the drug (C). Rats positive for 
none of the three criteria (0 criteria rats) are resistant to addiction, whereas rats that have three 
addiction-like criteria (3 criteria rats) are considered “addicted,” and represent 15 to 20% of the 
population initially exposed to cocaine (D). Importantly these behavioural differences are not 
attributable to differential levels of cocaine intake, since throughout protracted exposure 3 criteria and 0 
criteria rats do not differ in this measure (E). Although selected on three addiction-like criteria, 3criteria 
rats display complementary features of drug addiction, such as inability to limit drug intake when 
offered extended access to cocaine (F) and high vulnerability to relapse, as measured by reinstatement 
of cocaine seeking behaviour by increasing doses of non contingent cocaine infusions (G). A-E: after 
(11), F: after (8) 
Although 3crit rats do not differ significantly from 0crit rats in terms of cocaine self-
administration [26;28;166], 3crit rats eventually develop higher motivation for the drug, an 
inability to refrain from drug-seeking, and resistance to punishment [8;26;28;101;166]. 
More importantly, although selected on three addiction-like behaviours, 3crit rats also 
display enhanced escalation of cocaine self-administration as compared to 0crit rats (figure 
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6F). 3crit rats therefore fulfil a fourth criterion of addiction, namely an inability to control 
drug intake [26] classically established after extended access to the drug [21]. This results 
demonstrate that loss of control over drug intake does not necessarily follow extended 
access to the drug, but instead develops in some vulnerable subjects exposed to cocaine self-
administration for prolonged periods of time. 
The predictive validity of the model is further supported by de demonstration that 3crit rats 
also show a high vulnerability to relapse in response to non-contingent infusions of cocaine 
(figure 6G) [8] or contingent presentations of a drug-associated stimulus [26]. Thus, even 
though selected on three addiction-like criteria, after chronic exposure to cocaine, 3crit rats 
display important features of clinical addiction as defined in the DSM-IV. These 
observations provide the model with both construct and predictive validities. 
Moreover, since addiction-like behaviour emerges in three criteria rats only after extended 
exposure to the drug, i.e., after at least 50 daily self-administration sessions, these results 
highlight the importance of the interaction between a vulnerable phenotype and chronic 
drug exposure in the development of compulsive drug self-administration. 
6. Vulnerabilities to drug addictions  
Like many other psychiatric disorders, we are not all equally vulnerable to develop drug 
addiction. Epidemiological studies have revealed that between 15 to 35% of the population 
exposed to addictive drugs will develop compulsive drug use [167]. The results described in 
the previous section illustrate very well that inter-individual differences in vulnerability to 
develop compulsive cocaine self-administration can also be observed in rats. Thus, in any 
given population of rats exposed to cocaine only some develop addiction-like behaviour, 
thereby demonstrating that animal models provide a realistic estimate of risk for addiction 
in humans [41;166;169]. 
As already discussed, the underlying aetiology of the different pathways to addiction are 
likely to involve interactions between a vulnerable phenotype, environmental influences 
and drug exposure itself [170-171]. It is therefore important to identify the psychobiological 
substrates of vulnerability to develop compulsive drug use both in drug naive subjects and 
drug experienced individuals, thereby being able to develop preventive and therapeutic 
strategies at different stages of drug use history. 
6.1 Psychobiological factors of vulnerability to drug addiction: contribution of 
behavioural traits 
Epidemiological studies in human populations have revealed striking associations between 
drug use [172-173b], and certain behavioural traits [174-189] such as anxiety [190-193], 
impulsivity [187;194-195] and sensation-seeking [176;183;196-199]. The relevance of these 
traits for animal models of addiction is discussed below. 
6.1.1 Anxiety 
Anxiety can be assessed in preclinical models using various procedures which include the 
elevated plus maze (EPM) [200-201]. During the classic 5-min test session on the EPM a 
variety of behaviours are measured including the ratio of open and closed arms entries, time 
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spent in the open and closed arms, as well as self-grooming which are all indices of anxiety. 
High levels of anxiety including high grooming behaviour and a low percentage of time 
spent in the open arms of the EPM have been associated with an enhanced propensity to 
acquire cocaine CPP [202] as well as an increased motivation to self-administer cocaine 
[203], but see [204]. Trait anxiety has also been associated with an enhanced preference for 
alcohol [205-206], consistent with the notion that alcohol use may self-medicate underlying 
mood disorders related to anxiety and stress [207-208]. 
We have recently established that high anxiety in the EPM predicts escalation of cocaine, but 
not heroin self-administration in the rat (figure 7) [209]. 
 
Fig. 7. High anxiety trait predicts loss of control over cocaine, but not heroin, self- 
administration in the rat, after (122) 
High anxious (HA) and low anxious (LA) rats were selected in the upper and lower 33% of a Lister 
Hooded population (A & D). Whereas HA did not differ from either LA and the overall population in 
their escalation of heroin intake throughout 12 sessions of 6 h extended access to the drug (B) HA rats 
showed a marked increase in their cocaine intake as compared to LA or the overall population (E). 
Thus, high anxiety is related to the magnitude of cocaine escalation (F) whereas it is not related to the 
slope of escalation of heroin intake (C). 
These data suggest that if high anxiety trait may contribute to the choice of the drug used, 
i.e., preference for alcohol or opiates [210], it does not necessarily contribute to the 
development of compulsive use when the drug is initially used as a self-medication [211]. 
However, the striking relationship between high anxiety levels in the EPM and subsequent 
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vulnerability to escalate cocaine intake suggest that high anxiety may facilitate a tolerance to 
anxiogenic properties of cocaine [212] perhaps because of a ceiling effect, or, instead 
enhance the potential anxiolytic properties of cocaine that have been suggested for low 
doses of the drug [213]. 
6.1.2 Sensation seeking / Novelty-seeking 
Sensation- and novelty-seeking traits have been the focus of a large number of pre-clinical 
studies on addiction vulnerability (for review, see [12]). 
In preclinical studies, sensation/novelty seeking trait has been suggested to be modelled 
both by high locomotor reactivity to a new inescapable environment (high responder 
phenotype, HR) [214-215], and high propensity to visit a new environment in a free-choice, 
novelty-induced CPP, paradigm (high novelty preferring phenotype, HNP) [12;216]. 
Piazza and colleagues were the first to investigate the role of sensation-seeking in this 
context by measuring the locomotor response of rats to an inescapable novel environment 
[217]. In this model, rats are placed for two hours in a new environment and their horizontal 
activity is monitored. Based on inter-individual differences in locomotor response animals 
are either selected as high (HR) or low responders (LR) according to a median division [217]. 
HR rats show a greater propensity to acquire psychostimulant self-administration [217] 
since they more readily self-administer low doses of amphetamine than LR rats [2;217]. 
Moreover, HR rats show a greater propensity for drug-induced neural plasticity [218-219] 
and increased stress-evoked dopamine release in the Acb than LR rats [220]. 
However, sensation seeking does not predict the acquisition of CPP for addictive drugs, 
which instead is predicted by novelty-seeking [12;216;221-223], the latter being a 
behavioural trait dissociable from the former [9;28;224]. 
Novelty-seeking is normally assessed by measuring the preference of rats for a novel versus 
familiar compartment using a procedure quite similar to CPP [225], although broad 
methodological differences are observed in the literature that can impact onto the nature of 
the behavioural construct one is investigating. Indeed, depending on the study, novelty 
preference has been measured as (1) the number and time duration of visits of a new arm in 
a Y-maze during the first 2 or 5 min, respectively, of a test session taking place 30 min after 
the habituation to the other two arms of the set-up [226], (2), novelty-induced place 
preference tested for 15 min on the third day of a protocol during which animal were 
exposed 30 min daily to one compartment of a CPP box [223-224] whereas locomotor 
reactivity to novelty has been measured in (1) circular corridors [226-227], playground maze 
[228] or (2) activity chambers [216;229], each environment differing from one other in terms 
of light intensity, openness and area. 
Overall, animals selected as novelty-seekers, or novelty-preferring (HNP), are those that fall in 
the upper quartile range. Unlike animals selected from the lower quartile of the population, 
high novelty seekers readily develop a conditioned place preference to amphetamine [224;228] 
and self-administration of cocaine under an autoshaping procedure [230]. 
Thus, although both traits are dependent upon the dopaminergic system [12], they are 
mutually exclusive [12;216], but see [231] and therefore may predict different dimensions of 
vulnerability to drug addiction [12]. 
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We have investigated the respective role of HR and HNP phenotypes in inter-individual 
vulnerability to switch from controlled to compulsive cocaine SA. A cohort of rats were 
tested for their locomotor response to inescapable novelty and, subsequently for their 
preference propensity to express novelty-induced CPP. 
After extended cocaine self-administration these rats were tested for each of the three 
addiction-like criteria. Whereas LR and HR rats were highly represented in the 0 and 1crit 
populations, 60% of the LNP rats were included in the 0crit population as opposed to 70% of 
the HNP rats that showed 2 or 3 addiction-like criteria, none belonging to the 0crit 
population (figure 8A). This asymmetric distribution specific to LNP and HNP rats was 
further investigated, as illustrated in figure 8B-D which depict the representativity of LR, 
HR, LNP and HNP rats within the distributions for each of the addiction-like criteria. 
Importantly, HNP rats, as opposed to LNP rats, represented the great majority of the 




Fig. 8. High novelty preference (HNP) and sensation seekers (HR) rats are not equally 
distributed within the different addiction-like criteria. 
A. Addiction score.The great majority of HNP rats are represented in the 2 and 3crit subgroups of the 
population whereas HR rats are equally distributed throughout the different groups. B-C. HNP and 
LNP rats are distributed asymmetrically within the population relative to persistence of drug seeking 
(B) and motivation for the drug (C). LNP rats are clustered on the right side of the distribution whereas 
HNP rats are also represented in the right part of the distribution. Such asymmetry is not observed for 
LR and HR rats which are equally distributed throughout the overall population for these two criteria. 
D. Distribution of LNP, HNP, LR and HR rats for compulsive cocaine self-administration. Whereas LR 
and HR rats did not show any difference in their distribution throughout the population, HNP rats 
were highly clustered in the compulsive subpopulation as emphasised by the encircling square. Thus 
HNP rats may be highly vulnerable to compulsive cocaine self-administration. Analysis of data from 
(28) 
Thus although no differences were observed between HR and LR rats for their scores in 
each of their addiction-like criteria, HNP rats displayed higher scores than LNP rats in each 
of the addiciton-like criteria, namely resistance to punishment, inability to refrain from 
cocaine-seeking even if the drug is not available since they persisted, responded, more on 
the active nose-poke than LNP rats during “no-drug“ periods and motivation for cocaine 
(figure 9D). 
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Fig. 9. Novelty Preference, but not locomotor reactivity to novelty predicts the switch to 
compulsive cocaine self-administration. 
ANOVAs with HNP/LNP groups as between-subject factors revealed that HNP rats showed higher 
addiction score than LNP rats [F1,18=10.59, p<0.01] (A). Compared to LNP rats, HNP rats developed 
compulsive cocaine SA as measured by high level of resistance to punishment [F1,18=11.16, p<0.01] (B) 
and were unable to stop seeking cocaine when it was not available and signaled as so [F1,18=9.03, p<0.01] 
(C). HNP rats tend to show higher motivation for cocaine than LNP though this difference did not reach 
statistical significance (D). These behavioral differences between HNP and LNP rats could not be 
attributable to differential cocaine intake since the two groups have been exposed to the same amount 
of cocaine throughout the experiment [F1,18<1] (E). When compared to LR rats, HR rats showed no 
difference in the addiction-like behavioral measures. These two groups had behavioral scores similar to 
those of LNP rats, thereby illustrating that locomotor reactivity to novelty, as opposed to novelty 
preference, doesn’t predict addiction-like behavior for cocaine. 
The relationship between high novelty preference trait and vulnerability to switch to 
compulsive cocaine SA was further supported by a clear relationship assessed with a non 
parametric Spearman correlation analysis R=0.32, p<0.05, with the percentage of time spent 
in the new environment of the novelty-induced place preference procedure and the 
percentage of infusions compared to baseline when punished contingently by electric foot 
shocks as variables. However, no relationship was observed between locomotor reactivity to 
novelty and resistance to punishment (Spearman R=-0.15, p=0.36). Importantly, the 
behavioural differences observed between HNP and LNP rats cannot be attributed to a 
difference in the total amount of cocaine intake since the two groups did not differ for their 
total cocaine intake during the 60 days preceding the assessment of the addiction-like 
criteria [F1,18<1] (figure 9E). 
Since a great majority of the HNP, and none of the LNP, rats was clustered in the 
compulsive subpopulation, HNP rats, even though identified from a normally distributed 
population, may represent a specific sub-population vulnerable to compulsive cocaine 
intake after protracted exposure to the drug. Thereby the high novelty preference trait in the 
rat, as identified as the upper quartile of the population tested with the present paradigm is 
a promising behavioural tool for the study of the neurobiological substrates of vulnerability 
to compulsive cocaine intake. 
While providing the first evidence for a causal relationship between novelty preference and 
compulsive cocaine use, this study confirms that locomotor reactivity to novelty does not 
predict the vulnerability to develop cocaine addiction, but does rather predict the 
propensity to self-administer drugs [27;217]. Altogether, these data suggest that the HR 
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phenotype and its underlying neurobiological mechanisms may be involved in facilitating 
cocaine use, but not in the transition to switch from controlled to compulsive cocaine use, 
the hallmark of cocaine addiction [97]. 
Thus two different behavioural measures suggested to reveal a putative sensation/novelty 
seeking trait in rats [12], namely novelty-induced locomotor activity and novelty preference, 
are differentially predictive of inter individual propensity to self-administer cocaine and to 
switch from controlled to compulsive cocaine use, respectively. 
These preclinical data suggest that the correlates of the increased propensity shown by 
human sensation seekers to use addictive drugs [175] should be dissociated from those 
associated with the transition from controlled to compulsive drug use. Indeed, not only is 
sensation seeking a heterogeneous, multifaceted, construct [232] but it is quantified 
according to different, not necessarily overlapping [233], personality scales including the 
Zuckerman, Eysenck, Arnett and Cloninger’s scales. A factorial analysis of the different 
items of the sensation seeking scale developed by Zuckerman [197] revealed four 
dimensions [234] namely Thrill and Adventure Seeking [TAS], Experience Seeking [ES], 
Disinhibition [Dis], and Boredom Susceptibility [BS], of which the TAS and DIS sub-scales 
have been suggested to refer to sensation seeking whereas the ES and BS sub-scales would 
refer to novelty seeking [234-235]. Further research is needed to investigate which of these 
sub-scales is the most predictive of the vulnerability to switch to compulsive cocaine use, 
thereby clearly refining the relationships between sensation seeking trait and vulnerability 
to cocaine addiction. 
6.1.3 Impulsivity 
A popular paradigm used to assess impulsivity in rodents is the 5-choice serial reaction time 
task (5-CSRTT), which was developed originally as an analogue of the human continuous 
performance task of sustained attention [236]. The 5-CSRTT requires animals to detect brief 
flashes of light presented pseudo-randomly in one of five holes and to make a nose-poke 
response in the correct spatial location in order to receive a food reward. The rat is thus 
required to monitor a horizontal array of apertures and to withhold from responding until 
the onset of the stimulus. Generally, the accuracy of stimulus discrimination provides an 
index of attentional capacity, while premature responses – made before the presentation of 
the stimulus – are regarded as a form of impulsive behaviour and hence a failure in impulse 
control [237-238]. The neural and neurochemical basis of impulsivity on the 5-CSRTT has 
been extensively investigated, involving important contributions from the anterior cingulate 
cortex (ACC), infralimbic cortex, Acb, medial striatum and by the ascending monoaminergic 
systems [239-240]. 
More recently, the 5-CSRTT has been used to screen for spontaneously high levels of 
impulsivity in rats, a phenotype associated with increased cocaine, sucrose and nicotine self-
administration [241-243]. Interestingly, Dalley and colleagues have recently shown using 
microPET brain imaging that high impulsive rats have lower dopamine D2/3-binding levels 
in the ventral striatum as compared to low impulsive littermates [241], thereby suggesting 
that alteration of dopamine D2/3-receptors in the Acb may contribute to high impulsivity 
and vulnerability to drug addiction. 
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We have used the animal model of addiction-like behaviour for cocaine described in 
previous sections to investigate whether high impulsivity trait predicts the switch to 
compulsive cocaine SA. 
A cohort of 40 Lister Hooded rats was screened in the 5-CSRTT for their impulse control. 
These rats were then tested for their locomotor response to a new, inescapable environment. 
Thus, prior to cocaine exposure, rats were identified as high (HI) and low (LI) impulsive or 
HR and LR (figure 10). 
 
Fig. 10. Impulsivity and novelty-induced locomotor activity: two distinct phenotypes. After 
(27) 
On two baseline days (B), premature responses in the 5_CSRTT were measured. (A and B) During long 
intertrail intervals (LITIS), HI rats showed more premature responses than LI rats (Group: F3,36 = 14.4, 
p<0.01; scedule: F8,288 = 130.22, p<0.01; Schedule x Group: F24,288 = 7.01, p<0.01) (***p<0,001) (A) and HR 
(p<0.01) or LR rats (p<0.05) (B). HR rats did not differ from LR rats or from LI subjects (B). (C and D) 
HR rats were more reactive to novelty tha LR rats (F3,35 = 17.63, p<0.01). HI and LI subjects never 
differed from each other. *Comparison with HR: *p<0.05, **p<0.01, ***p<0.001. (D) Pink and blue dotted 
lines represent the average premature responses during the last two intertrial intervals for HI and LI 
rats, respectively. 
High impulsivity trait and locomotor response to novelty were demonstrated to be 
independent behavioural traits. We then tested whether high locomotor response to novelty 
and high impulsivity traits predicted higher propensity to acquire cocaine self-
administration. We allowed animals to acquire cocaine SA with daily increasing doses of the 
drug. We demonstrated that HR rats acquire cocaine self-administration at doses at which 
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LR rats do not, thereby confirming that HR rats are more prone to acquire stimulants self-
administration than LR animals [217]. However, HI rats did not differ from LI in their 
propensity to acquire cocaine SA (figure 11). 
 
 
Fig. 11. Novelty-induced locomotor activity predicts the propensity to acquire cocaine self- 
administration, after (27) 
(A) HR rats showed an upward shift of the cocaine dose-response curve compared with LR littermates 
(Group: F1,16 = 4.9, p<0.05; Dose: F6,96 = 11.73, p<0.01; Group x Dose: F6,96 = 4.39, p<0.01). HR rats infused 
more cocaine at the lowest three doses than vehicle (p<0.01). (B) HI and LI subjects did not differ in the 
number of self-administered cocaine infusions (Group: F1,16<1; Dose: F6,96 =10.79, p<0.01; Group x Dose: 
F6,96<1) 
When subsequently exposed to protracted cocaine self-administration and tested for their 
addiction-like behaviour, rats were identified as 0, 1, 2 and 3crit rats and each animal was 
given an addiction score (figure 12). We then retrospectively compared HI vs LI and HR vs 
LR rats for their addiction score and revealed that HI rats had higher addiction score than LI 
whereas HR did not differ from LR rats. 
This increased addiction score observed in HI rats was specifically attributed to the 
development of compulsive cocaine SA in these rats since they maintained cocaine SA 
despite punishment to the same extent as 3crit rats did. However, HR and LR rats did not 
differ in this behavioural criterion. The specific relationship between high impulsivity and 
compulsivity was further demonstrated by a correlational analysis between the percentage 
of premature responses in the 5-CSRTT and resistance to punishment, as assessed by a non 
parametric correlation analysis (figure 12). 
This evidence suggests that the predisposition to initiate drug use is independent of the 
vulnerability to shift from controlled to compulsive drug taking, and therefore provides 
new insights into the various behavioural and psychological factors that influence the 
pathways to addiction. In particular, the demonstration that the high impulsive trait 
predicts the shift to compulsive drug taking behaviour is of major interest since a shift from 
impulse control failure to compulsivity has been suggested to play a major role in the 
development of drug addiction in humans [87;244] (figure 13). 
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Together with the demonstration that novelty preference predicts addiction-like behaviour 
for cocaine [28] the present data suggest that further investigations should focus on the 
additive or interactive contribution of high impulsivity and novelty seeking traits to the 
vulnerability to switch to compulsive cocaine SA. 
This suggestion is timely since we [245] have recently demonstrated that high impulsive 
rats, as identified in the 5-CSRTT, prefer a novel compartment in a novelty-induced CPP 
procedure [245] (figure 14). 
Thus both novelty preference and impulsivity, but not locomotor response to novelty, 
contribute to inter-individual propensity to switch from controlled to compulsive cocaine SA. 
However, this conclusion may be taken with caution since it might be true only for stimulants. 
Indeed, we [122] have recently demonstrated that high impulsivity trait does not predict inter-
individual differences in escalation of heroin self-administration (figure 15). This propensity 
was instead predicted by pharmacological flexibility in response to extended access to heroin, 
i.e., increased titration in response to increased availability of the drug. 
 
Fig. 12. Impulsivity predicts the transition to compulsivity 
After extended exposure to cocaine SA 0, 1, 2 and 3crit rats were identified and were distributed 
similarly to previously described (A) in that 3 crit rats represented 20% of the overall population. When 
ranked on a linear addiction scale (R2 = 0.99, Group: F3,19=34.43, p<0.01), three-criteria rats had addiction 
scores (2.8 ± 0.6) above the standard deviation (2.1), and higher than all the other groups (B). (C) HI rats 
displayed higher addiction score than LI rats (F1,9 = 7.55, *p<0.05), whereas HR rats did not differ from 
LR rats. (D) HI rats (n=5) displayed higher resistance to punishment than LI rats (n=6) (F1,9 = 12.79, 
p<0.01), whereas HR (n=5) rats did not differ from LR rats (n=5). (E) Impulsivity predicts compulsive 
cocaine self-administration (R= 0.42, p<0.05). Gray and black shadings represent LI and HI rats, 
respectively. 
 




Fig. 13. Impulsivity and compulsivity in drug addiction. 
It has been suggested that a shift occurs from impulsivity to compulsivity in the control over drug seeking 
during the development of drug addiction (left). According to this theoretical framework, drug use is 
initially controlled by the positive reinforcing properties of drugs. However, when addiction develops 
drug taking is no longer controlled by positive reinforcement but, instead, is controlled by negative 
reinforcement and the need to avoid the negative consequences of withdrawal. Other theoretical 
frameworks suggest a contribution of both impulsivity and compulsivity to different stages of the 
addiction cycle (right). Impulsivity might then be associated with drug taking and relapse, whereas 
compulsivity might be associated with craving, bingeing and insensitivity to negative feedback.  
 
 
Fig. 14. High impulsive rats seek novelty 
HI rats explored the novel compartment of the CPP apparatus for significantly longer period of time 
compared with the familiar compartment, a preference that was not observed in LI rats (group x 
compartment interraction: F1,24 = 6.53, p=0,017; post hoc t-test p=0.031). Howerver, there was no 
significant difference between HI and LI rat in the total time spent in the novel compartment. LI rats 
showed a trend increase in time spent in the familiar compartment compared with HI rats (p=0.059).  
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Fig. 15. High impulsivity trait does not predict a greater propensity to escalate heroin SA. 
After (122) 
Extended access to heroin resulted in escalation of heroin SA over time in both HI and LI rats (a-d). 
After 5 days of 1-hour access to heroin, an 18-day 6-hour daily self-administration period was 
introduced. Following initiation of the LgA sessions, HI rats (n=5) and LI rats (n=5) did not differ in 
their time-dependent increase in active lever presses (a), heroin infusion (b), and intake (calculated as 
the amount of heroin self-administered by each rat in milligrammes per kilogramme bidy weight) (c). A 
dimentional analysis based on the overall population tested (n=19) did not reveal any correlation 
between the individual level of impulsivity (percentage of premature responses during the last two 7 s-
LITI sessions) and the propensity to escalated heroin SA (escalation score; calculated as the slope of 
intake over 18 days od LgA for each subject) (d). Consequently, HI and LI rats differed neither in their 
escalation slope (e) not in the increase of their ER (intake for each LgA day divided by intake for day 1) 
over the 18 LgA sessions (f). 
This observation is of interest since it suggests that pharmacological flexibility in response to 
changes in drug availability and individual propensity to titrate drug intake according to 
drug availability may protect against loss of control over heroin SA. Nevertheless, the 
marked dissociation between high impulsivity trait and individual propensity to lose 
control over heroin intake is in marked contrast with the demonstration that high 
impulsivity predicts increased vulnerability to lose control over cocaine SA [241]. Such 
dissociation suggests that heroin and cocaine addiction may not necessarily share common 
etiological factors, or, since impulsivity is a multifaceted construct [246], that other forms of 
impulsivity predict vulnerability to opiates addiction. 
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7. Conclusions 
Major advances in the understanding of the neurobiological substrates of addictive drugs 
and their short and long-term consequences on the brain have been provided by CPP or self-
administration models. Refined preclinical models, that go beyond drug reinforcement or 
neurobiological adaptations to repeated exposure to addictive drugs, hence with heuristic 
value with regards to the compulsive nature of drug seeking in drug addicts, have provided 
new insights into the aetiology and pathophysiology of drug addiction. Nevertheless, to 
date several critical behavioural aspects of drug addiction remain under-investigated, 
including the influence of alternative reinforcers during self-administration sessions and the 
role of environmental conditions, and especially environmental enrichment in inter-
individual vulnerability to switch to compulsive drug use. Additionally, the recent data we 
have acquired on inter-individual differences in loss of control over heroin intake and the 
marked dissociation between high impulsivity trait and escalation of heroin SA reveal the 
necessity to develop preclinical models of addiction-like behaviour for other classes of drugs 
than stimulants. Only then will we be able to determine whether drug addiction is one 
pathology characterised by common etiological and pathophysiological factors or whether it 
should instead be considered as multifaceted, with different etiological and 
pathophysiological pathways, depending, at least, on the drug [56]. 
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